Table 2. Summary of the data extraction for meta-analysis.
Author’s Name | Year | Country | HITHOC | Non-HITHOC | Reference | ||||
---|---|---|---|---|---|---|---|---|---|
Total # | MST (m) | RFI (m) | Total # | MST (m) | RFI (m) | ||||
van Sandick | 2008 | Netherlands | 20 | OS: 11 | 9 | 15 | OS: 29 | 19 | 15 |
DFS: 8 | DFS: 21 | ||||||||
Tilleman | 2009 | USA | 92 | 13.1 | 29 | 11 | 32 | ||
Lang-Lazdunski | 2012 | UK | 54 | 23 | 22 | 12.8 | 33 | ||
Sugarbaker | 2013 | USA | 72 | 35.3 | 27.1 | 31 | 228 | 12.8 | 16 |
Isik | 2013 | Turkey | 19 | 15.4 | 13 | 6 | 34 |
DFS: disease free survival; HITHOC: hyperthermic intrathoracic chemotherapy; MST: median survival time; OSR: overall survival rate; RFI: recurrence free interval